ES8401851A1 - Una composicion dispersable en agua. - Google Patents

Una composicion dispersable en agua.

Info

Publication number
ES8401851A1
ES8401851A1 ES517868A ES517868A ES8401851A1 ES 8401851 A1 ES8401851 A1 ES 8401851A1 ES 517868 A ES517868 A ES 517868A ES 517868 A ES517868 A ES 517868A ES 8401851 A1 ES8401851 A1 ES 8401851A1
Authority
ES
Spain
Prior art keywords
beta
pharmaceutical formulation
lactam antibiotics
soluble binder
conventional excipients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES517868A
Other languages
English (en)
Spanish (es)
Other versions
ES517868A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES517868A0 publication Critical patent/ES517868A0/es
Publication of ES8401851A1 publication Critical patent/ES8401851A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES517868A 1981-12-02 1982-12-01 Una composicion dispersable en agua. Expired ES8401851A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8136295 1981-12-02

Publications (2)

Publication Number Publication Date
ES517868A0 ES517868A0 (es) 1984-01-01
ES8401851A1 true ES8401851A1 (es) 1984-01-01

Family

ID=10526317

Family Applications (1)

Application Number Title Priority Date Filing Date
ES517868A Expired ES8401851A1 (es) 1981-12-02 1982-12-01 Una composicion dispersable en agua.

Country Status (9)

Country Link
EP (1) EP0080862B1 (OSRAM)
JP (1) JPS58109419A (OSRAM)
AU (1) AU9103782A (OSRAM)
DE (1) DE3266580D1 (OSRAM)
ES (1) ES8401851A1 (OSRAM)
HK (1) HK25086A (OSRAM)
MY (1) MY8600479A (OSRAM)
NZ (1) NZ202657A (OSRAM)
ZA (1) ZA828797B (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
FR2594334B1 (fr) * 1986-02-20 1990-01-12 Bristol Myers Co Composition pharmaceutique injectable a base d'amoxicilline
US5750685A (en) * 1987-01-29 1998-05-12 Smithkline Beecham, P.L.C. Process for preparing potassium clavulanate in rossette form
US5288861A (en) * 1987-01-29 1994-02-22 Beecham Group Plc Potassium clavulanate in rosette form
NZ223316A (en) * 1987-01-29 1989-10-27 Beecham Group Plc Crystalline potassium clavulanate and pharmaceutical compositions
EP0281200B1 (en) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
DE68916983T2 (de) * 1988-02-25 1995-01-19 Yamanouchi Europ Bv Verfahren zur Herstellung eines pharmazeutischen Granulats.
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
US5670170A (en) * 1990-04-27 1997-09-23 Beecham Group P.L.C. Pharamaceutical formulation
RU2096955C1 (ru) * 1991-03-01 1997-11-27 Е.И.Дюпон Де Немур Энд Компани Вододиспергируемая гранулированная пестицидная композиция, получаемая методом экструзии, и способ ее получения
GB9114950D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
NZ337247A (en) * 1995-09-07 2001-05-25 Smithkline Beecham Corp Pharmaceutical tablet formulation comprising 875mg amoxycillin
KR20040058360A (ko) * 1996-02-29 2004-07-03 후지사와 야꾸힝 고교 가부시키가이샤 합성 감미료
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
HRP970485A2 (en) * 1996-09-13 1998-08-31 Joerg Rosenberg Process for producing solid pharmaceutical forms
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
AU5241200A (en) * 1999-06-29 2001-01-31 Miciopharma Chemical Aktiengesellschaft Retard formulation of amoxicillin for oral administration
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
AT412344B (de) * 2001-04-12 2005-01-25 Sandoz Ag Hydrophobisierte teilchen von k-clavulanat
AT413983B (de) * 2001-04-12 2006-08-15 Sandoz Ag K-clavulanat in der form eines granulates
WO2004047808A1 (en) * 2002-11-26 2004-06-10 Lek Pharmaceuticals D.D. Pharmaceutical compositions comprising amoxicillin and clavulanic acid
US8715734B2 (en) 2004-02-24 2014-05-06 Sandoz Ag Amoxicilline instant granulate
CN1767818A (zh) * 2004-05-31 2006-05-03 三亚药品株式会社 含β－内酰胺抗生素的分散片剂及其制备方法
KR100638315B1 (ko) * 2004-07-23 2006-10-25 주식회사 대웅제약 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
WO2014144407A1 (en) 2013-03-15 2014-09-18 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof
JP2025153047A (ja) 2024-03-29 2025-10-10 サーモス株式会社 調理器用蓋

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532993A (en) * 1975-03-07 1978-11-22 Beecham Group Ltd Injectable antibiotic compositions
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate

Also Published As

Publication number Publication date
ES517868A0 (es) 1984-01-01
JPH026332B2 (OSRAM) 1990-02-08
EP0080862B1 (en) 1985-09-25
HK25086A (en) 1986-04-11
DE3266580D1 (en) 1985-10-31
JPS58109419A (ja) 1983-06-29
EP0080862A1 (en) 1983-06-08
ZA828797B (en) 1983-09-28
MY8600479A (en) 1986-12-31
NZ202657A (en) 1985-05-31
AU9103782A (en) 1983-06-09

Similar Documents

Publication Publication Date Title
ES8401851A1 (es) Una composicion dispersable en agua.
CA981678A (en) (2-imidazolin-2-ylamino) substituted - quinoxalines and-quinazolines as antihypertensive agents
NZ198241A (en) Tablet containing amoxycillin and potassium clavulanate
IL65749A0 (en) Sparingly soluble salts of aminoglycoside antibiotics
IL69960A0 (en) Oral dosage form of beta-lactam antibiotics
CA969623A (en) Systeme d'alimentation pour ozoneur
AU556380B2 (en) I.v. administration with dry powder additive dissolution
CA982591A (en) Racemic and (+)-cis-1,3-dibenzyl-hexahydro-1h-thieno-(3,4-d)imidazole-2,4-dione
CA976609A (en) Dispositif de charge rapide d'accumulateurs etanches
AU7271981A (en) Beta-lactam antibiotics
AU558593B2 (en) Hetero cyclyl azetidine antibiotics
IT1149052B (it) Formulazione granulare mista ad azione prolungata, in particolare per la somministrazione orale di antibiotici
DE2960973D1 (en) Beta-lactam antibiotics, process for their preparation, fodder additives, drugs and process for their preparation
AU530789B2 (en) Amoxycillin composition
CA989839A (en) 5-(3-iodopropargyloxy) pyrimidine
GB1435814A (en) Pharmaceutical compositions containing pyrrolidone-carboxylic acid or a derivative thereof
CA983947A (en) Nitrogen-containing compounds and use thereof
AU8113282A (en) Beta-lactam antibiotics
IL55206A (en) Pharmaceutical compositions comprising clavulanic acid and certain beta-lactam antibiotics
JPS57146780A (en) Beta-lactam antibiotic, composition and manufacture
ES8507147A1 (es) Un procedimiento para la preparacion de derivados del acido penicilanico 6alfa-o-6beta-sustituidos.
AU549784B2 (en) Lyophilised penicillins
IE812714L (en) Antibiotic composition
AU3483871A (en) Biologically active compound
ZA817238B (en) Beta-lactam antibiotics their preparation and their use